Start Codon, One Nucleus Partner to Support Start-Ups in Accelerator Program

News
Article

Life science and healthcare business accelerator, Start Codon, and membership organization, One Nucleus, have partnered up to support the life science ecosystem in the United Kingdom.

Life science and healthcare business accelerator, Start Codon, and membership organization, One Nucleus, have partnered up to support the life science ecosystem in the United Kingdom, it was revealed in a Dec. 11, 2019 press release.

Under the terms of the partnership, One Nucleus will support and profile the life science and healthcare start-up companies that are taking part in the Start Codon accelerator program. The partnership will commence on Jan. 6, 2020 and will see One Nucleus provide Start Codon cohort companies with gold membership benefits for a 12-month period.

“Like Start Codon, One Nucleus is committed to playing an active and supportive role in enabling the success of the UK life science cluster, particularly that in the East of England and London,” said Dr. Jason Mellad, CEO at Start Codon, in the press release. “Having One Nucleus membership benefits will be extremely valuable to our cohort, particularly for developing a network of industry leading contacts.”

Tony Jones, CEO at One Nucleus, added, “One Nucleus can provide local, UK-wide and international connectivity to enable companies to maximise their performance within the life sciences and healthcare industry. Therefore, we are excited to partner with Start Codon to help facilitate the next generation of innovative and entrepreneurial companies.”

Source: Start Codon

 

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content